Abstract:Amyloid pathology is thought to accelerate tau propagation via neuronal connections in individuals at high risk for Alzheimer's disease (AD). Carriers of AD-causing mutations have elevated levels of amyloid pathology several years before tau accumulation. We hypothesized that the earliest tau pathology will be associated with connectivity abnormalities in the uncinate fasciculus, a tract innervating the entorhinal cortex. Further, we examined the association between white matter abnormalities, age and cognitive performance. 15 non-demented carriers from the Colombian-kindred (age range =28-45 years, Figure 1) underwent PiB-PET, Flortaucipir- FTP PET, diffusion tensor imaging (DTI) and memory testing (CERAD Word List Learning). The DTI-data were processed with TRACULA (FreeSurfer), tract of interest was the uncinate fasciculus (UF) and the control tract was the angular cingulum bundle (CB). Regional FTP was measured in entorhinal (EC) and inferior temporal (IT, control region) cortices. PiB was measured in a neocortical aggregate region. We performed Spearman's rank correlations (also partialling out age) to investigate associations between tau, diffusion metrics and memory. Demographics of the carriers. Higher levels of left EC tau pathology were associated with higher axial diffusivity (AxD), higher mean diffusivity (MD) and higher radial diffusivity (RD) in the UF in the carriers (Figure 2). The associations for MD and RD remained significant after controlling for age (r=0.55,p=0.04; r=0.58, p=0.03 respectively). Spatial analyses showed that group differences in the relationship between EC tau and UF diffusion occurred close to the EC (Figure 3). No associations were found for the right side or the CB tract or IT tau (all p>0.05). Left UF diffusivity did not correlate with memory performance or MMSE scores (with or without controlling for age, all p>0.05). The association between entorhinal tau pathology and diffusion in the uncinate fasciculus in preclinical autosomal dominant Alzheimer's disease Note: the interaction group by EC tau pathology on tract diffusivity is plotted and statistical significance for the interaction is provided in the panels (corrected for age, robust regressions). Note the limited range in tau pathology in the non- carriers. Abbreviations: FA = Fractional Anisotropy, MD = Mean Diffusivity, AxD = Axial Diffusivity, RD = Radial Diffusivity, EC = Entorhinal cortex, UF = uncinate fasciculus spatial distribution of the group differences of the association between entorhinal tau pathology and uncinate fasciculus diffusivity Note: for each voxel along the center of the tract, we plotted the p-values (see scale bar) for the Spearman's rank correlations between entorhinal tau and mean diffusivity of the uncinate fasciculus in carriers. Red/orange voxels indicate where the interaction was significant at p< 0.05. Consistent with figure 2, we observed mostly left-sided effects. The sagittal plane view was slightly rotated along the z-axis for optimal viewing of the morphology of the tracts. These results suggest that EC tau pathology in PSEN1 E280A mutation carriers is associated with diffusion abnormalities in connected tracts, several years before clinical onset. They also suggest that tau may propagate via neuronal connectivity rather than proximity. Larger samples sizes, including a control group, will be necessary to investigate differences between carriers and non-carriers for the interaction between white matter and tau pathology on memory performance.

Cognitive phenotype and neurodegeneration associated with Tau in Huntington's disease

Cerebellar Atrophy and Its Contribution to Cognition in Frontotemporal Dementias.

A soluble truncated tau species related to cognitive dysfunction and caspase-2 is elevated in the brain of Huntington's disease patients

Mild cognitive impairment in Huntington's disease: challenges and outlooks

Treatment with Tau fibrils impact Huntington's disease-related phenotypes in cell and mouse models

Genetic topography and cortical cell loss in Huntington's disease link development and neurodegeneration

Protein tau phosphorylation in the proline rich region and its implication in the progression of Alzheimer's disease

CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's disease.

P3‐399: ASSOCIATION BETWEEN CORTICAL THINNING AND TAU PATHOLOGY IN PRECLINICAL AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE

Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease

Huntingtin CAG repeats in neuropathologically confirmed tauopathies: Novel insights

Distinct biological property of tau in tau‐first cognitive proteinopathy: Evidence by longitudinal clinical neuroimaging profiles and compared with late‐onset Alzheimer disease

Prediction of Cognitive Heterogeneity in Parkinson's Disease: A 4-Year Longitudinal Study Using Clinical, Neuroimaging, Biological and Electrophysiological Biomarkers

Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology

P4‐299: TAU ACCUMULATION IN THE ENTORHINAL CORTEX AND PRECUNEUS IS ASSOCIATED WITH CORTICAL AMYLOID‐BETA BURDEN, AGE AND WORSE MEMORY PERFORMANCE IN PRECLINICAL AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE

P2‐461: ENTORHINAL TAU PATHOLOGY IS ASSOCIATED WITH WHITE MATTER ABNORMALITIES IN UNCINATE FASCICULUS IN PRECLINICAL AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE

An HDAC6-dependent Surveillance Mechanism Suppresses Tau-Mediated Neurodegeneration and Cognitive Decline

Convergence of presenilin- and tau-mediated pathways on axonal trafficking and neuronal function.

Behavior and Amyloid Profiles Modify the Association of Tauopathy/neurodegeneration and Cognitive Decline in Alzheimer’s Disease

CSF Tau phosphorylation at Thr205 is associated with loss of white matter integrity in autosomal dominant Alzheimer disease

Multiparametric characterization of white matter alterations in early stage Huntington disease